References
- Bencze, J., Seo, W., Hye, A., Aarsland, D., & Hortobagyi, T. (2020). Dementia with Lewy bodies - a clinicopathological update. Free Neuropathology, 1(7), 1 -12. https://doi.org/10.1789/freeneuropathology-2020-2613
- Chin, K., Teodorczuk, A., & Watson, R. (2019). Dementia with Lewy bodies: Challenges in the diagnosis and management. Australian & New Zealand Journal of Psychiatry, 53(4), 291 -303. https://doi.org/10.1177/0004867419835029
- Coon, E., Cutsforth-Gregory, J., & Benarroch, E. (2018). Neuropathology of autonomic dysfunction in synucleinopathies. Movement Disorders, 33(3), 349-358. https://doi.org/10.1002/mds.27186
- Creese, B., Ballard, C., Aarsland, D., Londos, E., Sharp, S., & Jones, E. (2014). Determining the Association of the 5HTTLPR Polymorphism with Delusions and Hallucinations in Lewy Body Dementias. The American Journal of Geriatric Psychiatry, 22(6), 580-586. https://doi.org/10.1016/j.jagp.2012.11.001
- Cromarty, R., Elder, G., Graziadio, S., Baker, M., Bonanni, L., & Onofrj, M. et al. (2016). Neurophysiological biomarkers for Lewy body dementias. Clinical Neurophysiology, 127(1), 349-359. https://doi.org/10.1016/j.clinph.2015.06.020
- Cuervo, A. (2004). Impaired Degradation of Mutant -Synuclein by Chaperone-Mediated Autophagy. Science, 305 (5688), 1292-1295. https://doi.org/10.1126/science.1101738
- Donaghy, P., & McKeith, I. (2014). The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis. Alzheimer’s Research & Therapy, 6(4), 46. https://doi.org/10.1186/alzrt274
- Dugger, B., Adler, C., Shill, H., Caviness, J., Jacobson, S., Driver-Dunckley, E., & Beach, T. (2014). Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism & Related Disorders, 20(5), 525-529. https://doi.org/10.1016/j.parkreldis.2014.02.012
- Fujishiro, H., Iseki, E., Nakamura, S., Kasanuki, K., Chiba, Y., & Ota, K. et al. (2013). Dementia with Lewy bodies: early diagnostic challenges. Psychogeriatrics, 13(2), 128-138. https://doi.org/10.1111/psyg.12005
- Fukui, T., Oowan, Y., Yamazaki, T., & Kinno, R. (2013). Prevalence and Clinical Implication of Microbleeds in Dementia with Lewy Bodies in Comparison with Microbleeds in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders Extra, 3(1), 148-160. https://doi.org/10.1159/000351423
- Huber, M., Beyer, L., Prix, C., Schönecker, S., Palleis, C., & Rauchmann, B. et al. (2019). Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies. Movement Disorders, 35(4), 595-605. https://doi.org/10.1002/mds.27945
- Jellinger, K., & Korczyn, A. (2018). Are dementia with Lewy bodies and Parkinson’s disease dementia the same disease?. BMC Medicine, 16(1). https://doi.org/10.1186/s12916-018-1016-8
- Kane, J., Surendranathan, A., Bentley, A., Barker, S., Taylor, J., & Thomas, A. et al. (2018). Clinical prevalence of Lewy body dementia. Alzheimer’s Research & Therapy, 10(1). https://doi.org/10.1186/s13195-018-0350-6
- Klein, J., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., & Vollmar, S. et al. (2010). Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology, 74(11), 885-892. https://doi.org/10.1212/wnl.0b013e3181d55f61
- Kon, T., Tomiyama, M., & Wakabayashi, K. (2019). Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases. Neuropathology, 40(1), 30 -39. https://doi.org/10.1111/neup.12597
- Lee, G., Cummings, J., Decourt, B., Leverenz, J., & Sabbagh, M. (2019). Clinical drug development for dementia with Lewy bodies: past and present. Expert Opinion on Investigational Drugs, 28(11), 951-965. https://doi.org/10.1080/13543784.2019.168 1398
- Lim, X., Yeo, J., Green, A., & Pal, S. (2013). The diagnostic utility of cerebrospinal fluid alpha-synuclein analysis in dementia with Lewy bodies —/INS; a systematic review and meta-analysis. Journal of The Neurological Sciences, 333, e296-e297. https://doi.org/10.1016/j.jns.2013.07.1117
- Londos, E., Hansson, O., Rosén, I., & Englund, E. (2019). Extreme sleep pattern in Lewy body dementia: a hypothalamic matter?. BMJ Case Reports, 12(3), e228177. https://doi.org/10.1136/bcr-2018-228177
- Matar, E., Ehgoetz Martens, K., Halliday, G., & Lewis, S. (2019). Clinical features of Lewy body dementia: insights into diagnosis and pathophysiology. Journal of Neurology, 267(2), 380-389. https://doi.org/10.1007/s00415-019-09583-8
- Matar, E., Shine, J., Halliday, G., & Lewis, S. (2019). Cognitive fluctuations in Lewy body dementia: towards a pathophysiological framework. Brain, 143(1), 31-46. https://doi.org/10.1093/brain/awz311
- McCleery, J., Morgan, S., Bradley, K., Noel-Storr, A., Ansorge, O., & Hyde, C. (2015). Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd010633 .pub2
- McKeith, I., Boeve, B., Dickson, D., Halliday, G., Taylor, J., & Weintraub, D. et al. (2017). Diagnosis and management of dementia with Lewy bodies. Neurology, 89(1), 88-100. https://doi.org/10.1212/wnl.0000000000004058
- Mollenhauer, B., & Schlossmacher, M. (2010). CSF synuclein: adding to the biomarker footprint of dementia with Lewy bodies. Journal of Neurology, Neurosurgery & Psychiatry, 81(6), 590-591. https://doi.org/10.1136/jnnp.2010.206391
- Nedelska, Z., Ferman, T., Boeve, B., Przybelski, S., Lesnick, T., & Murray, M. et al. (2015). Pattern of brain atrophy rates in autopsy-confirmed dementia with Lewy bodies. Neurobiology of Aging, 36(1), 452-461. https://doi.org/10.1016/j.neurobiolaging.2014.07.005
- Olanow, C., Perl, D., DeMartino, G., & McNaught, K. (2004). Lewy-body formation is an aggresome-related process: a hypothesis. The Lancet Neurology, 3(8), 496-503. https://doi.org/10.1016/s1474-4422(04) 00827-0
- Schumacher, J., Peraza, L., Firbank, M., Thomas, A., Kaiser, M., & Gallagher, P. et al. (2019). Dysfunctional brain dynamics and their origin in Lewy body dementia. Brain, 142(6), 1767-1782. https://doi.org/10.1093/brain/awz069
- Spillantini, M., & Goedert, M. (2006). The α-Synucleinopathies: Parkinson’s Disease, Dementia with Lewy Bodies, and Multiple System Atrophy. Annals of The New York Academy of Sciences, 920(1), 16-27. https://doi.org/10.1111/j.1749-6632.2000.tb06900.x
- Surendranathan, A., Kane, J., Bentley, A., Barker, S., McNally, R., & Bamford, C. et al. (2021). Introduction of an assessment toolkit associated with increased rate of DLB diagnosis. Alzheimer’s Research & Therapy, 13(1). https://doi.org/10.1186/s13195-021-00786-8
- Surendranathan, A., Rowe, J., & O’Brien, J. (2015). Neuroinflammation in Lewy body dementia. Parkinsonism & Related Disorders, 21(12), 1398-1406. https://doi.org/10.1016/j.parkreldis.2015.10.009
- Taylor, J., McKeith, I., Burn, D., Boeve, B., Weintraub, D., & Bamford, C. et al. (2020). New evidence on the management of Lewy body dementia. The Lancet Neurology, 19(2), 157-169. https://doi.org/10.1016/s1474-4422(19)30153-x
- Thomas, A., Taylor, J., McKeith, I., Bamford, C., Burn, D., Allan, L., & O’Brien, J. (2018). Revision of assessment toolkits for improving the diagnosis of Lewy body dementia: The DIAMOND Lewy study. International Journal of Geriatric Psychiatry, 33(10), 1293-1304. https://doi.org/10.1002/gps.4948
- Thomas, A., Taylor, J., McKeith, I., Bamford, C., Burn, D., Allan, L., & O’Brien, J. (2016). Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study. International Journal of Geriatric Psychiatry, 32(12), 1280-1304. https://doi.org/10.1002/gps.4609
- Valera, E., & Masliah, E. (2015). Combination therapies: The next logical Step for the treatment of synucleinopathies?. Movement Disorders, 31(2), 225-234. https://doi.org/10.1002/mds.26428
- van Dellen, E., de Waal, H., van der Flier, W., Lemstra, A., Slooter, A., & Smits, L. et al. (2015). Loss of EEGNetwork Efficiency Is Related to Cognitive Impairment in Dementia with Lewy Bodies. Movement Disorders, 30(13), 1785-1793. https://doi.org/10.1002/mds.26309
- Vann Jones, S., & O’Brien, J. (2013). The prevalence and incidence of dementia with Lewy bodies: a systematic review of population and clinical studies. Psychological Medicine, 44 (4), 673-683. https://doi.org/10.1017/s0033291713000494
- Wakabayashi, K., Mori, F., Tanji, K., Orimo, S., & Takahashi, H. (2010). Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain. Acta Neuropathologica, 120(1), 1-12. https://doi.org/10.1007/s00401-010-0706-x
- Walker, Z., Possin, K., Boeve, B., & Aarsland, D. (2015). Lewy body dementias. The Lancet, 386(10004), 1683-1697. https://doi.org/10.1016/s0140-6736(15)00462-6
- Yamada, M., Komatsu, J., Nakamura, K., Sakai, K., Samuraki-Yokohama, M., Nakajima, K., & Yoshita, M. (2020). Diagnostic Criteria for Dementia with Lewy Bodies: Updates and Future Directions. Journal of Movement Disorders, 13(1), 1-10. https://doi.org/10.14802/jmd.19052
- Yousaf, T., Dervenoulas, G., Valkimadi, P., & Politis, M. (2018). Neuroimaging in Lewy body dementia. Journal of Neurology, 266(1), 1-26. https://doi.org/10.1007/s00415-018-8892-x
- Zweig, Y., & Galvin, J. (2014). Lewy body dementia: the impact on patients and caregivers. Alzheimer’s Research & Therapy, 6(2), 21. https://doi.org/10.1186/alzrt251